Medtronic forward PE MDT
Share price divided by analysts' consensus earnings for the next twelve months, since 1996.
- Today, Oct 23, 2026
- 15.9×
- 10-year median
- 17.3×
- Against its 10-year history
- 20th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 13.0× to 40.2×
- Peer median
- 18.5×
Medtronic's forward PE is 15.9× as of Oct 23, 2026.
That is below its ten-year median of 17.3×, lower than on 80% of days in the last ten years.
Over that time it ranged from 13.0× in May 2026 to 40.2× in Feb 2020.
The median for 7 medical device stocks of a similar size is 18.5×.
Forward PE over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 15.9× | 13.0× | 18.4× |
| 2025 | 17.2× | 14.7× | 18.8× |
| 2024 | 14.7× | 14.4× | 17.0× |
| 2023 | 16.0× | 13.6× | 17.8× |
| 2022 | 15.2× | 15.0× | 21.5× |
| 2021 | 19.4× | 18.9× | 25.2× |
| 2020 | 22.6× | 21.4× | 40.2× |
| 2019 | 37.1× | 15.9× | 37.3× |
| 2018 | 17.3× | 15.9× | 19.9× |
| 2017 | 17.0× | 16.1× | 19.1× |
| 2016 | 15.7× | 15.7× | 19.9× |
| 2015 | 18.0× | 15.5× | 19.9× |
| 2014 | 18.6× | 14.5× | 19.0× |
| 2013 | 15.0× | 11.8× | 15.4× |
| 2012 | 11.3× | 10.1× | 12.5× |
| 2011 | 11.1× | 9.3× | 12.7× |
| 2010 | 11.1× | 9.7× | 14.7× |
| 2009 | 14.1× | 8.3× | 14.1× |
| 2008 | 10.2× | 9.9× | 20.3× |
| 2007 | 20.3× | 18.8× | 23.7× |
Against its peers
Companies in Medical - Devices nearest Medtronic's size, closest first, today.
| Company | Forward PE |
|---|---|
| MDTMedtronic | 15.9× |
| SYKStryker | 19.3× |
| ABTAbbott Laboratories | 17.7× |
| BSXBoston Scientific | 14.1× |
| EWEdwards Lifesciences | 28.3× |
| GEHCGE HealthCare Technologies | 13.8× |
| DXCMDexCom | 27.7× |
| ZBHZimmer Biomet | n/m |
| Peer median | 18.5× |
Where Medtronic ranks
What the forward PE tells you
Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.
Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.
More on Medtronic
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.